v3.20.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Jan. 31, 2020
Jan. 31, 2019
Operating activities    
Net income (loss) $ 1,162,100 $ (15,171)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 232,461 48,744
Changes in non-cash working capital balances    
Accounts receivable 6,000 (35,000)
Contracts receivable 15,000
Investments (1,410,796)  
Accounts payable (235)
Interest payable – related party 12,183  
Accrued expenses (12,742) (3,426)
Deferred revenue (15,086) 54,975
Cash provided by (used in) operating activities (10,880) 49,887
Financing activities    
Payments on bank loan (3,743)
Payments on related party note (4,300)
Payments on demand note (7,000)
Proceeds from sale of common stock 5,000
Cash used in financing activities (4,300) (5,743)
Increase (decrease) in cash and cash equivalents during the period (15,180) 44,144
Cash and cash equivalents, beginning of the period 19,110 1,655
Cash and cash equivalents, end of the period 3,930 45,799
Cash paid for:    
Interest 2,120 5,461
Income taxes
Non-cash financing activities    
Common stock issued as prepaid compensation $ 915,000